Education
About Us
Working with TipRanks
Follow Us
BioInvent International AB (BOVNF)
OTHER OTC:BOVNF
Total Valuation
BioInvent International AB has a market cap or net worth of $242.25M. The enterprise value is $1.90B.
Market Cap$242.25M
Enterprise Value$1.90B
Share Statistics
BioInvent International AB has 65,804,360 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding65,804,360
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioInvent International AB’s return on equity (ROE) is -0.48 and return on invested capital (ROIC) is -52.17%.
Return on Equity (ROE)-0.48
Return on Assets (ROA)-0.43
Return on Invested Capital (ROIC)-52.17%
Return on Capital Employed (ROCE)-0.53
Revenue Per Employee378.69K
Profits Per Employee-3.99M
Employee Count118
Asset Turnover0.05
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio3.06
Price to Fair Value2.86
Price to FCF-5.29
Price to Operating Cash Flow-5.43
PEG Ratio0.56
Income Statement
In the last 12 months, BioInvent International AB had revenue of 44.69M and earned -429.38M in profits. Earnings per share was -6.53.
Revenue44.69M
Gross Profit44.69M
Operating Income-471.06M
Pretax Income-429.24M
Net Income-429.38M
EBITDA-409.38M
Earnings Per Share (EPS)-6.53
Cash Flow
In the last 12 months, operating cash flow was -434.57M and capital expenditures -10.52M, giving a free cash flow of -445.08M billion.
Operating Cash Flow-434.57M
Free Cash Flow-445.08M
Free Cash Flow per Share-6.76
Dividends & Yields
BioInvent International AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.10
52-Week Price Change-10.84%
50-Day Moving Average3.30
200-Day Moving Average3.34
Relative Strength Index (RSI)55.17
Average Volume (3m)15.45K
Important Dates
BioInvent International AB upcoming earnings date is Aug 26, 2025, Before Open (Confirmed).
Last Earnings DateApr 29, 2025
Next Earnings DateAug 26, 2025
Ex-Dividend Date―
Financial Position
BioInvent International AB as a current ratio of 9.91, with Debt / Equity ratio of 1.97%
Current Ratio9.91
Quick Ratio9.79
Debt to Market Cap0.00
Net Debt to EBITDA1.02
Interest Coverage Ratio0.00
Taxes
In the past 12 months, BioInvent International AB has paid 135.00K in taxes.
Income Tax135.00K
Effective Tax Rate>-0.01
Enterprise Valuation
BioInvent International AB EV to EBITDA ratio is -5.17, with an EV/FCF ratio of -5.42.
EV to Sales47.35
EV to EBITDA-5.17
EV to Free Cash Flow-5.42
EV to Operating Cash Flow-5.56
Balance Sheet
BioInvent International AB has $742.21M in cash and marketable securities with kr15.19M in debt, giving a net cash position of -$727.02M billion.
Cash & Marketable Securities$742.21M
Total Debtkr15.19M
Net Cash-$727.02M
Net Cash Per Share-$11.05
Tangible Book Value Per Share$13.46
Margins
Gross margin is 100.00%, with operating margin of -1054.15%, and net profit margin of -960.87%.
Gross Margin100.00%
Operating Margin-1054.15%
Pretax Margin-960.57%
Net Profit Margin-960.87%
EBITDA Margin-916.14%
EBIT Margin-959.33%
Analyst Forecast
The average price target for BioInvent International AB is $4.08, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$4.08
Price Target Upside24.01% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―